CDHA CAAR

“BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed),” (RFA-DA-23-039, a reissue of RFA-EB-20-002, National Institute on Aging, in conjunction with other agencies, application deadlines Dec. 15, 2022, Sept. 12, 2023, and Sept. 12, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-039.html

A. “HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed),” (RFA-NS-23-006, a reissue of RFA-NS-20-011, National Institute on Aging in conjunction with other ageinces, application deadlines Jan. 4, April 4, and Sept. 4). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed),” (RFA-NS-23-007).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-006.html

B. “HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required),” (RFA-NR-23-001, National Institute on Aging, application deadline Nov. 21, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NR-23-001.html

“NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 – Clinical Trial Not Allowed),” (RFA-DA-23-037, National Institute on Aging, in conjunction with other agencies, application deadline November 29, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-037.html

“Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed),” (RFA-AG-23-018, National Institute on Aging, application deadline February 3, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-018.html

A. “Optimization of Genome Editing Therapeutics for Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) (U01 – Clinical Trials Not Allowed),” (RFA-NS-23-017, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 30, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-017.html

B. “HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed),” (RFA-EB-22-002, National Institute on Aging, in conjunction with other agencies, application deadlines Nov. 14, 2022, June 19, 2023, Feb. 20, 2024, Oct. 15, 2024, June 17, 2025).

grants.nih.gov/grants/guide/rfa-files/RFA-EB-22-002.html

C. “NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed),” (PAR-22-227, a reissue of RFA-AG-22-004, National Institute on Aging, application deadlines Nov. 15, 2022, Oct. 18, 2023, and Oct. 17, 2024). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed),” (PAR-22-226).

grants.nih.gov/grants/guide/pa-files/PAR-22-227.html

“Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimer’s Disease/Alzheimer’s Disease Related Dementias (AD/ADRD) (K18 Clinical Trial Not Allowed),” (RFA-NS-22-061, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 4, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-061.html

A. “Alzheimer’s-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional),” (RFA-AG-23-025, a reissue of RFA-AG-18-002, National Institute on Aging, application deadline Oct. 21, 2022). . Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional),” (RFA-AG-23-026); and, “Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional),” (RFA-AG-23-027).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-025.html

B. “Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed),” (RFA-NS-22-059, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 31, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-059.html

C. “HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional),” (RFA-NS-23-003, a reissue of RFA-NS-22-016, National Institute on Aging, in conjunction with other agencies, application deadlines Oct. 10, 2022, June 13, 2023, June 10, 2024, and June 9, 2025).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-003.html

D. “Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional),” (RFA-OD-22-014, a Reissue of RFA-OD-19-013, National Institute on Aging, in conjunction with other agencies, application deadlines September 30, 2022 and August 15, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-014.html

“Geroscience Course (R25 Independent Clinical Trial Not Allowed),” (PAR-22-214, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 21, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-214.html

A. “HEAL Initiative: Coordinated Pain Care in Health Care Systems Research Program – Coordinating Center (U24 Clinical Trial Not Allowed),” (RFA-NS-22-065, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 4, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 – Clinical Trial Optional),” (RFA-NS-22-053).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-065.html

B. “Functional Target Validation for Alzheimer’s Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed),” (RFA-NS-22-055, a reissue of RFA-NS-19-015, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 8, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-055.html

C. “BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional),” (RFA-MH-22-240, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 17, 2023 and Feb. 15, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-240.html

A. “More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional),” (RFA-AG-23-021, National Institute on Aging, application deadline Oct. 20, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-021.html

B. “HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required),” (RFA-DA-23-041, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 27, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional),” (RFA-DA-23-042).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-041.html

C. “BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed),” (RFA-EB-22-001, National Institute on Aging, in conjunction with other agencies, application due dates Oct. 13, 2022, Oct. 13, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-EB-22-001.html

D. “Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed),” (RFA-OD-22-015, National Institute on Aging, in conjunction with other agencies, application due dates Oct. 27, 2022, Oct. 27, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-015.html

A. “Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional),” (PAS-22-196, a reissue of PAS-19-316, National Institute on Aging, in conjunction with other agencies, application deadline Jan. 5, April 5, and Sept. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional),” (PAS-22-197).

grants.nih.gov/grants/guide/pa-files/PAS-22-196.html

B. “Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed),” (RFA-AG-23-033, National Institute on Aging, application deadline Oct. 21, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-033.html

A. “Network for Personalization of Diagnostic Tests for Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional),” (RFA-AG-23-032, National Institute on Aging, application deadline Oct. 17, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-032.html

B. “Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes, Including in Populations that Experience Health Disparities (U01 Clinical Trial Required),” (RFA-NS-23-001, National Institute on Aging, application deadline Sept. 15, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-001.html

“Request for Workshop Proposals – Center for Demography of Health and Aging,” (deadline for application is July 15, 2022). The Center for Demography of Health and Aging invites interested investigators to submit proposals for workshop funding for 2022-2023.

www.ssc.wisc.edu/cdha/cinfo/CDHA workshop-solicitation-6.13.22.docx

“Measures and Methods for Research on Family Caregivers for People Living with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed),” (RFA-AG-23-022, National Institute on Aging, application deadline Oct. 20, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Measures and Methods for Research on Family Caregivers for People Living with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed),” (RFA-AG-23-023).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-022.html

“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in Major Disasters Declared by the President,” (HHS-2022-ACL-AOA-DASG-0068, application deadline Sept. 6, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335690

“PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed),” (PA-22-176, a reissue of PA-21-259, National Institute on Aging, in conjunction with other agencies, application deadlines Sept. 5, 2022, Jan. 5, 2022, and April 5, 2023). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required),” (PA-22-177); “PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),” (PA-22-178); and, “PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required),” (PA-22-179).

grants.nih.gov/grants/guide/pa-files/PA-22-176.html

“Treatments for Lewy Body Dementias and Frontotemporal Dementias–Exploratory Clinical Trial (U01 Clinical Trial Required),” (RFA-NS-22-056, National Institute on Aging, in conjunction with other agencies, application deadline November 21, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-056.html

“Dissemination and Implementation Research in Health (R01 Clinical Trial Optional),” (PAR-22-105, a reissue of PAR-19-274, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 5, Jun. 5, and Oct. 5). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed),” (PAR-22-106); “Dissemination and Implementation Research in Health (R21 Clinical Trial Optional),” (PAR-22-109).

grants.nih.gov/grants/guide/pa-files/PAR-22-105.html

“Supporting State and Community Innovations in Dementia-Specific Respite Programs and Services,” (HHS-2022-ACL-AOA-ADPI-0087, application deadline June 27, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=339599

“Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional),” (RFA-AG-23-031, National Institute on Aging, application deadline Oct. 17, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-031.html

“Native American Elder Justice Initiative,” (HHS-2022-ACL-AOA-IERC-0070, application deadline June 21, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337806

“Lifespan Respite Care Program: Grants to New States and States Re-Establishing Their Core Respite Infrastructures,” (HHS-2022-ACL-AOA-LRLR-0050, application deadline June 17, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335011

A. “Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed),” (RFA-AG-23-019, National Institute on Aging, application deadline Oct. 18, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-019.html

B. “Neuronal Vulnerability to Proteinopathies in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Not Allowed),” (RFA-AG-23-028, National Institute on Aging, application deadline July 15, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-028.html

“Tribal Long Term Service and Support Resource Center,” (HHS-2022-ACL-AOA-IELT-0069, application deadline April 27, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337233

“Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed),” (RFA-AG-23-016, a reissue of RFA-AG-22-026, National Institute on Aging, application deadlines Oct. 21, 2022, Oct. 20, 2023, and Oct. 18, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-016.html

A. “Elder Justice Innovation Grants – Enhancing APS Approaches to Cases Involving Opioids and Substance Use Disorders FY2022 ,” (HHS-2022-ACL-AOA-EJIG-0072, application deadline May 3, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337805

B. “Elder Justice Innovation Grants – Improving Guardianship FY2022,” (HHS-2022-ACL-AOA-EJIG-0071, application deadline May 6, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337804

C. “Alzheimer’s Disease Programs Initiative (ADPI) – States and Community Grants,” (HHS-2022-ACL-AOA-ADPI-0059, application deadline May 24, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335000

D. “Legal Assistance Enhancement Program,” (HHS-2022-ACL-AOA-LAEP-0054, application deadline May 3, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335225

E. “Elder Justice Innovation Grants – Improving Results for APS Clients FY2022,” (HHS-2022-ACL-AOA-EJIG-0055, application deadline May 6, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335067

A. “INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed),” (RFA-OD-22-007, a reissue of RFA-OD-20-004, National Institute on Aging, in conjunction with other agencies, application deadline July 1, 2022, June 30, 2023, and July 1, 2024). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed),” (RFA-OD-22-009); “Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required),” (RFA-OD-22-010).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-007.html

B. “Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed),” (RFA-OD-22-011, National Institute on Aging, in conjunction with other agencies, application deadline May 31, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-011.html

A. “Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional),” .(PAR-22-132, National Institute on Aging, in conjunction with other agencies, application deadline July 27, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-132.html

B. “Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional),” (PAR-22-145, a 4eissue of PAR-19-093, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-22-145.html

A. “Focused Technology Research and Development (R01 Clinical Trial Not Allowed),” (PAR-22-127, a reissue of PAR-19-253, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and . Oct. 5). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Technology Development Research for Establishing Feasibility and Proof of Concept (R21 – Clinical Trial Not Allowed),” (PAR-22-126).

grants.nih.gov/grants/guide/pa-files/PAR-22-127.html

B. “BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed),” (RFA-MH-22-220, a reissue of of RFA-MH-21-135, National Institute on Aging, in conjunction with other agencies, application deadlines June 10, 2022, Oct. 14, 2022, June 9, 2023, Oct. 13, 2022, June 7, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-220.html

A. “NIA Program Project Applications (P01 Clinical Trial Optional),” (PAR-22-130, a reissue of PAR-19-314, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PAR-22-130.html

B. “Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional),” (PAR-22-104, a reissue of PAR-21-230, National Institute on Aging, in conjunction with other agencies, application deadline July 13, 2022, July 13, 2023, and July 15, 2024).

grants.nih.gov/grants/guide/pa-files/PAR-22-104.html

C. “Bioengineering Partnerships with Industry (U01 Clinical Trial Optional),” (PAR-22-123, National Institute on Aging, in conjunction with other agencies, application deadlines May 26 and Sept. 26).

grants.nih.gov/grants/guide/pa-files/PAR-22-123.html

“Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Optional),” (PAR-22-115, National Institute on Aging, in conjunction with other agencies, application deadline April 22, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Coordinating Center to Support Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (U24 Clinical Trial Not Allowed),” (PAR-22-120).

grants.nih.gov/grants/guide/pa-files/PAR-22-115.html

A. “Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed),” (RFA-AG-23-010, National Institute on Aging, application deadline July 15, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R21 Clinical Trial Not Allowed),” (RFA-AG-23-011).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-011.html

B. “BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs – eTeamBCP (U01 Clinical Trials Optional),” (RFA-NS-22-028, a reissue of RFA-NS-20-029, National Institute on Aging, in conjunction with other agencies, application deadline Jun. 14, 2022, June 15, 2023, and June 14, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-028.html

A. “BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed),” (RFA-NS-22-026, a reissue of RFA-NS-21-013, National Institute on Aging, in conjunction with other agencies, application deadlines Jul. 1, 2022, Oct. 6, 2022, June 30, 2023, Oct. 4, 2023, June 28, 2024, and Oct. 2, 2024). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed),” (RFA-NS-22-027).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-026.html

B. “HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional),” (RFA-NS-22-050, National Institute on Aging, in conjunction with other agencies, application deadlines March 11, 2022, June 23, 2022, Oct. 13, 2022, and Feb. 23, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-050.html

“Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional),” (PAR-22-097, a reissue of PAR-21-311, National Institute on Aging, in conjunction with other agencies, application deadlines Nov. 15, 2022, Nov. 15, 2023, and Nov. 15, 2024). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)” (PAR-22-098).

grants.nih.gov/grants/guide/pa-files/PAR-22-097.html

A. “NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed),” (PAR-22-110, National Institute on Aging, renewal deadlines May 25 and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PAR-22-110.html

B. “HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed),” (RFA-NS-22-018, National Institute on Aging, in conjunction with other agencies, application deadlines March 17, 2022, July 7, 2022, Oct. 11, 2022, and March 9, 2023). Note: There is a companion funding announcements (follow the link under ‘Companion Funding Opportunity”): “HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed),” (RFA-NS-22-021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-018.html

A. “BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional),” (RFA-MH-22-115, a reissue of RFA-MH-19-135, National Institute on Aging, in conjunction with other agencies, application deadlines June 7, 2022, June 7, 2023, and June 7, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-115.html

B. “Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional),” (PAR-22-078, a reissue of PAR-20-167, National Institute on Aging, in conjunction with other agencies, application deadlines June 24, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-078.html

A. “Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed),” (PAR-22-058, National Institute on Aging, in conjunction with other agencies, application deadlines March 15, 2022, Aug. 1, 2022, and May 1, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-22-058.html

B. “HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed),” (RFA-DE-22-011, National Institute on Aging, in conjunction with other agencies, application deadline March 31, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-DE-22-011.html

C. “Stimulating Access to Research in Residency (StARR) (R38),” (RFA-HL-23-006, a reissue of of RFA-HL-18-023, National Institute on Aging, in conjunction with other agencides, application deadlines March 15, 2022, March 15, 2023, and March 15, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-006.html

D. “BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed),” (RFA-MH-22-145, a reissue of RFA-MH-20-128, National Institute on Aging, in conjunction with other agencies, application deadlines June 14, 2022, June 14, 2023, and June 14, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-145.html

E. “Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional),” (RFA-MH-22-175, a reissue of RFA-MH-21-145, application deadline March 18, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional),” (RFA-MH-22-176).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-175.html

F. “HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required),” (RFA-NS-22-037, National Institute on Aging, in conjunction with other agencies, application deadlines March 22, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-037.html

G. “Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed),” (RFA-TR-22-011, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 28, 2022, Aug. 22, 2022, and May 23, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-012.html

H. “Emergency Awards: HEAL Initiative-Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Research Network (ERN) (U24 Clinical Trial Not Allowed),” (RFA-TR-22-012, National Institute on Aging, in conjunction with other agencies, application deadline March 15, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-012.html

I. “Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed),” (RFA-TR-22-013, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 28, 2022, Aug. 22, 2022, and May 22, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-013.html

“Innovations in Nutrition Programs and Services -Research,” (HHS-2022-ACL-AOA-INNU-0017, application closing date March 10, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335746

A. “Early and Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease/Alzheimer’s Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional),” (PAR-21-359, a reissue of PAR-18-877 and PAR-18-878, National Institute on Aging, application deadlines Mar. 4, 2022, June 5, 2022, Oct. 5, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-21-359.html

B. “Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional),” (PAR-21-360, National Institute on Aging, application deadlines Mar. 4, 2022, June 17, 2022, Oct. 18, 2022, Feb. 17, 2023, June 19, 2023, Oct. 18, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-21-360.html

C. “Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required),” (PAR-21-357, a reissue of PAR-19-135, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 25, June 25, and Oct. 25). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed),” (PAR-22-060).

grants.nih.gov/grants/guide/pa-files/PAR-21-357.html

D. “Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 – Clinical Trials Optional),” (PAR-22-092, National Institute on Aging, in conjunction with other agencies, application deadlines Mar. 18, 2022, June 5, 2022, Feb. 5, 2023, June 5, 2023, Feb. 5, 2024, and June 5, 2024).

grants.nih.gov/grants/guide/pa-files/PAR-22-092.html

“Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed),” (PAR-22-057, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 18, 2022, Aug. 1, 2022, and May 1, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-22-057.html

A. “Lipids in Brain Aging and Alzheimer’s Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed),” (RFA-AG-23-009, National Institute on Aging, application deadline June 14, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-009.html

B. “HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional),” (RFA-DA-22-034, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-034.html

C. “HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional),” (RFA-DA-22-046, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-046.html

D. “HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional),” (RFA-DA-22-043, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-043.html

E. “HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional),” (RFA-DA-22-047, National Institute on Aging, in conjunction with other agencies, application deadline March 10, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Pilot & Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional),” (RFA-DA-22-048).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-047.html

A. “NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional),” (PAR-22-077, National Institute on Aging, application dates March 15, 2022, Oct. 18, 2022, Feb. 15, 2023, Oct. 17, 2023, Feb. 15, 2024, and Oct. 17, 2024).

grants.nih.gov/grants/guide/pa-files/PAR-22-077.html

B. “Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional),” (PAR-22-093, a reissue of PAR-19-070, National Institute on Aging, in conjunction with other agencies, application deadlines Mar. 11, 2022, July 8, 2022, Nov. 14, 2022, Mar. 10, 2023, July 10, 2023, Nov. 13, 2023, March 11, 2024, July 9, 2024, and Nov. 12, 2024). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Optional),” (PAR-22-094).

grants.nih.gov/grants/guide/pa-files/PAR-22-093.html

C. “Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed),” (PAS-22-096, a reissue of PAS-19-105, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAS-22-096.html

D. “Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed),” (RFA-AG-23-003, National Institute on Aging, application deadline March 3, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-003.html

E. “HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed),” (RFA-DA-22-044, National Institute on Aging, in conjuction with other agencies, application deadline March 10, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed),” (RFA-DA-22-045).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-044.html

F. “Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional),” (RFA-MH-22-135, National Institute on Aging, in conjunction with other agencies, application deadlines March 15, 2022 and Oct. 15, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional),” (RFA-MH-22-136).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-135.html

A. “Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed),” (PAR-22-031, a reissue of PAR-19-147, National Institute on Aging, in conjunction with other agencies, application deadline Feb 5, June 5, and Oct. 5). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed),” (PAR-22-032).

grants.nih.gov/grants/guide/pa-files/PAR-22-031.html

B. “Resource Networks for Protein Polymorphisms in Alzheimer’s Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed),” (RFA-AG-22-030, a reissue of RFA-AG-21-012, National Institute on Aging, application deadline January 10, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-030.html

C. “BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed),” (RFA-NS-22-011, a 4eissue of RFA-NS-19-006, National Institute on Aging, in conjunction with other agencies, application Feb. 15, 2022, Oct. 14, 2022, June 14, 2023, Feb. 14, 2024, and Oct. 11, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-011.html

A. “2022 Empowering Communities to Deliver and Sustain Evidence-Based Falls Prevention Programs,” (HHS-2022-ACL-AOA-FPSG-0031, application deadline January 25, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335002

B. “2022 Empowering Communities to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs,” (HHS-2022-ACL-AOA-CSSG-0041, application deadline January 25, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335066

“Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional),” (PAR-22-047, a reissue of PAR-18-820, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-22-047.html

A. “Steven H. Sandell Grant Program,” (application deadline January 31, 2021).

crr.bc.edu/about-us/grant-programs/steven-h-sandell-grant-program-2/

B. “Dissertation Fellowship Program,” (application deadline January 31, 2021).

crr.bc.edu/about-us/grant-programs/dissertation-fellowship-program-2/

C. “Undergraduate Fellowship Program,” (application deadline January 31, 2021).

crr.bc.edu/about-us/grant-programs/undergraduate-fellowship-program/

A. “Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed),” (PAR-22-059, National Institute on Aging, in conjunction with other agencies, application deadline February 5, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-059.html

B. “Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed),” (RFA-AG-22-026, National Institute on Aging, application deadline October 22, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-026.html

A. “Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional),” (RFA-AG-23-001, National Institute on Aging, application deadline March 3, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-001.html

B. “Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed),” (RFA-AG-23-002, National Institute on Aging, application deadline March 3, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-002.html

C. “Limited Competition: NIH Health Care Systems Research Collaboratory – Coordinating Center (U24 Clinical Trial Not Allowed),” (RFA-AT-22-002, National Institute on Aging, in conjunction with other agencies, application deadline December 15, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AT-22-002.html

A. “NIH Health Care Systems Research Collaboratory – Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional),” (RFA-AT-22-001, National Institute on Aging, in conjunction with other agencies, application deadlines December 15, 2021, June 17, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AT-22-001.html

B. “NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed),” (RFA-NS-21-025, National Institute on Aging, in conjunction with other agencies, application deadline November 1, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-025.html

“Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed),” (PAR-22-048, National Institute on Aging, in conjunction with other agencies, application deadline March 11, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-048.html